Showing results (261-270 of 283) with videos related to

Sort By:
Pageof 29
Nature Microbiology|September 2, 2020
Fluoxazolevir inhibits hepatitis C virus infection in humanized chimeric mice by blocking viral membrane fusionChristopher D Ma, Michio Imamura, Daniel C Talley, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 28, 2015
Improvement of renal dysfunction in a patient with hepatitis C virus-related liver cirrhosis by daclatasvir and asunaprevir combination therapy: A case reportMasataka Tsuge, Akira Hiramatsu, Fumi Shinohara, et al.
Plos One|January 18, 2022
The importance of body composition assessment for patients with advanced hepatocellular carcinoma by bioelectrical impedance analysis in lenvatinib treatmentKenji Yamaoka, Kenichiro Kodama, Tomokazu Kawaoka, et al.
BMC Gastroenterology|June 2, 2022
Efficacy and safety of chemoradiation therapy using one-shot cisplatin via hepatic arterial infusion for advanced hepatocellular carcinoma with major macrovascular invasion: a single-arm retrospective cohort studyKensuke Naruto, Tomokazu Kawaoka, Kenichiro Kodama, et al.
Journal of Medical Virology|July 18, 2018
Advanced liver fibrosis effects on the response to sofosbuvir-based antiviral therapies for chronic hepatitis CKei Morio, Michio Imamura, Yoshiiku Kawakami, et al.
Internal Medicine (Tokyo, Japan)|October 22, 2020
Efficacy of Lusutrombopag for Thrombocytopenia in Patients with Chronic Liver Disease Scheduled to Undergo Invasive ProceduresYuno Nishida, Tomokazu Kawaoka, Michio Imamura, et al.
BMC Gastroenterology|June 28, 2023
Impact and usefulness of the transition to the new MAFLD classification for non-B, non-C HCC: a retrospective cohort studyYusuke Johira, Takashi Nakahara, Takahiro Kinami, et al.
Oncology|March 7, 2021
Comparison of the Clinical Outcome of Ramucirumab for Unresectable Hepatocellular Carcinoma with That of Prior Tyrosine Kinase Inhibitor TherapyKei Amioka, Tomokazu Kawaoka, Yutaro Ogawa, et al.
Medicine|October 22, 2021
Advanced hepatocellular carcinoma with response to lenvatinib after atezolizumab plus bevacizumabShigeki Yano, Tomokazu Kawaoka, Yusuke Johira, et al.
International Journal of Cancer|September 2, 2022
The presence of vessels encapsulating tumor clusters is associated with an immunosuppressive tumor microenvironment in hepatocellular carcinomaPeiyi Zhang, Atsushi Ono, Yasutoshi Fujii, et al.
Pageof 29